ArticleAsian journal of andrology2023

Enzalutamide and olaparib synergistically suppress castration-resistant prostate cancer progression by promoting apoptosis through inhibiting nonhomologous end joining pathway.

Hui-Yu Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.